mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.4 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.4 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.4 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.4 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.4 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.4 |